Mass General Brigham partners with AvoMD to enhance rapid response care workflows, integrating digital tools into clinical processes via EHR… Continue Reading
Articles
Telix Boosts Isotope Production | Acquires ARTMS Technology
Telix Pharmaceuticals Limited is acquiring ARTMS Inc., a leading radioisotope production technology firm. The deal includes ARTMS’ advanced cyclotron-based isotope… Continue Reading
Ness Therapeutics Acquisition | Elevating Cancer Immunotherapy Potentials
Eilean Therapeutics LLC has acquired Ness Therapeutics Inc in an equity transaction, gaining access to their leading PTPN2 inhibitors for… Continue Reading
Salvo Health Raises $5M to Transform GI Healthcare
Salvo Health, a digital GI care startup, secures $5M in Seed Prime funding led by City Light Capital and Human… Continue Reading
Moxe Health’s $25M Boost from Trinity Reshapes Data Exchange
Moxe Health secures $25M from Trinity Capital for its healthcare data exchange tools. Their convergence product enables payers to input… Continue Reading
Absci’s $75M Offering: Powering Drug Innovation and Growth
Absci Corporation (Nasdaq: ABSI) announces a $75 million public offering to support internal drug development, enhance their Integrated Drug Creation™… Continue Reading
Alamar Biosciences: $128M Boost for Precision Proteomics
Alamar Biosciences secures $128M, led by Sands Capital, for their precision proteomics platform. Series C funding, totaling nearly $250M, will… Continue Reading
Recce Pharmaceuticals and MCRI: Fighting Infectious Diseases Together
Recce Pharmaceuticals extends collaboration with Murdoch Children’s Research Institute, focusing on their Anti-Infective Research (AIR) Unit. Led by Dr. Sohinee… Continue Reading
Intelligent Bio Solutions and Cliantha Research Collaborate
Intelligent Bio Solutions Inc. partners with Cliantha Research for a pharmacokinetic study as part of FDA 510(k) pathway. The study,… Continue Reading
Dyadic-Rabian Alliance: Revolutionizing Rabies Prevention Worldwide
Dyadic International partners with Rabian BV to develop affordable rabies prophylactics using its C1 protein production platform. The collaboration aims… Continue Reading